DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

InterContinental San Francisco

2018年11月05日 (月) 午前 7:00 - 2018年11月06日 (火) 午後 3:00

888 Howard Street, San Francisco, CA 94103

Real World Evidence Conference

This conference has reached maximum capacity.

Session 6: Patient Contributed Data

Session Chair(s)

Marni  Hall, PhD, MPH

Marni Hall, PhD, MPH

Vice President and General Manager, Global Regulatory Science and Strategy

IQVIA, United States

This session will focus on patient-generated health data (PGHD). Different types of PGHD, such as structured and unstructured forms, and criteria for their use will be discussed. Case studies of assessment and application of use of PGHD for clinical and regulatory decision-making will be shared. Concrete steps for advancing greater use of PGHD will be outlined

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe different types of PGHD
  • Formulate evaluation method(s) to validate use of PGHD for a specific purpose
  • Identify opportunities for pilot projects to advance the use of PGHD

Speaker(s)

Emily  Drabant Conley, PhD

23andMe: Innovation in Clinical Trial Recruitment

Emily Drabant Conley, PhD

23andMe, United States

Vice President of Business Development

Christine  Lemke

Patient Contributed Data

Christine Lemke

Evidation Heath, Inc., United States

Co-Founder & President

Sally  Okun, BSN, MHS, MBA, RN

Patient Contributed Data

Sally Okun, BSN, MHS, MBA, RN

Clinical Trials Transformation Initiative (CTTI), United States

Executive Director

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。